Thomas W Hodge, Iii

Title: Thomas W Hodge, III: Innovator in Viral Infection Treatment

Introduction

Thomas W Hodge, III is a notable inventor based in Athens, GA, who has made significant contributions to the field of viral infection treatment. His innovative approach focuses on methods to treat and prevent infections caused by viruses classified in Baltimore group V.

Latest Patents

Hodge holds a patent for "Methods of treating and prophylactically protecting mammalian patients infected by viruses classified in Baltimore group V." This patent outlines a groundbreaking method for treating viral infections in mammals through the systemic administration of ranpirnase and three other homologous ribonucleases. The experimental results disclosed in the patent demonstrate effectiveness against various viruses, including rabies, MERS-CoV, influenza, Ebola, Chikungunya, Venezuelan equine encephalitis, canine parvovirus, adenovirus-2, respiratory syncytial virus, rhinovirus-14, and vaccinia.

Career Highlights

Hodge is associated with Tamir Biotechnology, Inc., where he continues to advance his research and development efforts in the field of virology. His work has the potential to significantly impact the treatment of viral infections, providing new avenues for therapeutic interventions.

Conclusion

Thomas W Hodge, III is a pioneering inventor whose work in viral infection treatment showcases the importance of innovation in addressing public health challenges. His contributions through patented methods highlight the potential for new treatments that can save lives and improve health outcomes.